Free medicines for blood cancer available.

According to this message, India’s Adyar Cancer Institute is distributing, free of charge, a medicine named ‘Imitinef Mercilet’ that cures blood cancer. The message is circulating rapidly via email and is also making its way around the Internet via blogs, forums and social networking websites.

The Adyar Cancer Institute is a real health facility located in the city of Chennai, India and, as its name implies, it indeed specializes in cancer treatment and research. The Adyar Cancer Institute has achieved great results in the treatment and research of cancer since its establishment in 1954.

I contacted a spokesperson at the Adyar Cancer Institute to ask about the veracity of the message. He sent me the following reply:

Only the Part of this message is true. The medicine Imitinef is available free for only qualified persons and not for all. It is free for those who have admitted in the hospital for treatment.

‘Imitinef Mercilet’ is apparently an alternative spelling of the drug Imatinib mesylate which is used in the treatment of some forms of leukemia along with other types of cancer. Imatinib, often referred to a “Gleevec”, has proved to be an effective treatment for some forms of cancers. However, “blood cancer” is a generalized term for cancers that affect the blood, lymphatic system or bone marrow. The three types of blood cancer are listed as leukemia, lymphoma, and multiple myeloma. These three malignancies require quite different kinds of treatments. While drugs (including Imatinib), along with other treatments such as radiation can help to slow or even stop the progress of these cancers, there is currently no single drug treatment that can be said to actually cure all such cancers.

Moreover, it should be noted that Imatinib is available for cancer patients in many different health facilities around the world, not just the Adyar Cancer Institute.

Thus, although there are some elements of truth to this message, its is also potentially misleading and contains inaccurate information.

Dear Rizwan,

good information and initiation.

Regards,

MSR.Murty

Modern oncology has achieved significant breakthroughs in the development of innovative drugs for various types of cancer. Molecularly targeted therapies, for example, can precisely target mutations in cancer cells, improving treatment efficacy and minimizing side effects. Immunotherapy activates the patient's own immune system to fight cancer cells, read more at fenbendazole.org. New gene therapy methods have also been developed to replace or repair damaged genes. These innovations make it possible to personalize treatment according to the unique characteristics of each patient's tumor and significantly improve the survival prognosis and quality of life of cancer patients.